Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Avascular Necrosis of the Head of Humerus clinical trials

1 of 2 indexed Avascular Necrosis of the Head of Humerus trials are currently recruiting.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Avascular Necrosis of the Head of Humerus: 2 US clinical trials tracked, 1 recruiting.

Avascular Necrosis of the Head of Humerus is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Catalyst OrthoScience, running 1 of these trials.

Enrollment posture brief

Registry condition avascular-necrosis-of-the-head-of-humerus

OPEN 1 | RECR 50% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Avascular Necrosis of th (th…50%
Open-enrollment share among volume-matched conditions near Avascular Necrosis of the Head of Humerus

Avascular Necrosis of the Head of Humerus lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Avascular Necrosis of the Head of Humerus on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Avascular Necrosis of the Head of Humerus is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Avascular Necrosis of the Head of Humerus records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Shoulder iD™ Primary Reversed Glenoid Device
1 trials
Catalyst CSR Total Shoulder System Device
1 trials

US sites by state

Facility locations filed on Avascular Necrosis of the Head of Humerus trials. A trial with sites in several states counts in each.

Virginia 1 trials
Texas 1 trials
Rhode Island 1 trials
Oregon 1 trials
Ohio 1 trials
Michigan 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Avascular Necrosis of the Head of Humerus page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Avascular Necrosis of the Head of Humerus trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Catalyst OrthoScience sponsors the most Avascular Necrosis of the Head of Humerus trials on record, review their full trial history before evaluating a specific study. See Catalyst OrthoScience's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Avascular Necrosis of the Head of Humerus condition card totals 2 registered trials; most-linked intervention Shoulder iD™ Primary Reversed Glenoid; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.